New Aptivus launched in Europe for resistant HIV
November 9, 2005Sales and Marketing
Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been approved by the EMEA.The prevalence of drug-resistant HIV is …
UK approval for severe asthma treatment Xolair
November 9, 2005Sales and Marketing
Novartis has received UK approval for Xolair, its novel monoclonal antibody treatment for severe persistent allergic asthma.The first drug in …
Tarceva receives approval for pancreatic cancer in the US
November 8, 2005Sales and Marketing
Roche and Genentech's Tarceva has been approved in the US for the treatment of pancreatic cancer – one of the …
Pharma’s changing salesforces
November 8, 2005Sales and Marketing
The traditional salesforce model has served the industry well for 30-40 years and has been one of the biggest drivers …
US acquisitions a coup for Cambridge Antibody
November 8, 2005Research and Development
Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …
Industry’s European price ‘free riding’ claim refuted
November 8, 2005Sales and Marketing
Long-standing claims that the US has been burdened with high medicines prices because of 'free riding' by European countries have …
NHS clinical leaders oppose mergers
November 8, 2005More than three quarters of lead clinicians believe proposed mergers of Primary Care Trusts will harm patient care, according to …
R&D Scoreboard poor gauge of pharma investment in the UK
November 8, 2005Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard
The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
Marketers and levels of leadership
November 7, 2005Sales and Marketing
Trends come and go in the pharma industry – just like in any other – but one which has stuck …
Prescribing powers proposed for new NHS support workers
November 4, 2005Around 3,000 new healthcare support workers will provide clinical care across primary and secondary care, according to the government's latest …
NICE unveils fast track process
November 3, 2005Sales and Marketing
Cancer drugs will be the first treatments to benefit from changes designed to speed up the way NICE makes its …
200,000 quitters to boost NRT sales
November 3, 2005Sales and Marketing
Manufacturers of nicotine replacement therapy products can expect sales to rise when England's partial smoking ban is introduced.The government anticipates …
Radical change for NHS in Scotland
November 3, 2005Healthcare services across Scotland are to focus on preventative care as part of wide-ranging changes to NHS priorities in the …
Government retreat on handing over PCT services
November 3, 2005The government has retreated on plans for a mandatory opening up of primary care services to alternative providers.Health secretary Patricia …
Don’t blush…look before you flush’
November 3, 2005Medical Communications
Bowel Cancer UK has been launched with a new campaign to promote personal awareness of the disease that kills 16,000 …
Galliard wins GSK and Pfizer accounts
November 3, 2005Medical Communications
Galliard Healthcare Communications has won the global PR account for GlaxoSmithKline's Avodart and been appointed by Pfizer to handle UK …
Tamiflu’s frontline status a mixed blessing for Roche
November 3, 2005Sales and Marketing
Sales of Roche's Tamiflu have rocketed as governments around the world prepare for a potential pandemic, but its status as …
Waking up to new ways of training
November 3, 2005Business Services
From sales forecasts to the marketing mix, from business information to regulatory project management, there are as many training courses, …
GSK inspires more confidence than shaky AstraZeneca
November 1, 2005Research and Development
The UK's two pharma giants have posted strong growth in the third quarter, but investor doubts about AstraZeneca's long-term prospects …
National campaign promotes private healthcare
November 1, 2005Sales and Marketing
Six of the UK's biggest private hospital and health insurance companies have joined forces to promote the benefits of private …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
